Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001961863-24-000307
Filing Date
2024-08-29
Accepted
2024-08-29 18:43:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2817
  Complete submission text file 0001961863-24-000307.txt   4585
Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Subject) CIK: 0001991792 (see all company filings)

EIN.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41925 | Film No.: 241265289
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CG ONCOLOGY, INC. 400 SPECTRUM CENTER DRIVE, SUITE 2040 IRVINE CA 92618
Business Address C/O CG ONCOLOGY, INC. 400 SPECTRUM CENTER DRIVE, SUITE 2040 IRVINE CA 92618 (949) 409-3700
Charming Jade Ltd (Reporting) CIK: 0002008426 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 144